Literature DB >> 23850794

A permeation method for detection of self-aggregation of doxorubicin in aqueous environment.

Zoltán Fülöp1, Ruxandra Gref, Thorsteinn Loftsson.   

Abstract

For pharmaceutical scientists, it is important to know if dissolved drug molecules are present only as monomers or in the form of aggregates in a test solution or formulation. Amphiphilic or hydrophobic drugs frequently self-associate to form dimers, trimers or higher order aggregates. Doxorubicin aggregation was examined by a previously developed permeation technique to detect oligosaccharide aggregation in aqueous solutions. At very low doxorubicin concentrations dimers and trimers have been observed, but in aqueous 0.5mg/ml doxorubicin solutions aggregates containing about 40 molecules were observed. The permeation studies were supported by TEM studies. The results indicate that neutral doxorubicin molecules aggregate more readily than the protonated ones. Doxorubicin aggregation is a stepwise process resulting in formation of aggregates of variable sizes are enhanced aggregation with increasing doxorubicin concentration.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aggregation; Doxorubicin; Permeation; Self-association

Mesh:

Substances:

Year:  2013        PMID: 23850794     DOI: 10.1016/j.ijpharm.2013.06.058

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  19 in total

Review 1.  Advances in Biomaterials and Technologies for Vascular Embolization.

Authors:  Jingjie Hu; Hassan Albadawi; Brian W Chong; Amy R Deipolyi; Rahul A Sheth; Ali Khademhosseini; Rahmi Oklu
Journal:  Adv Mater       Date:  2019-06-06       Impact factor: 30.849

2.  Engineering hairy cellulose nanocrystals for chemotherapy drug capture.

Authors:  Sarah A E Young; Joy Muthami; Mica Pitcher; Petar Antovski; Patricia Wamea; Robert Denis Murphy; Reihaneh Haghniaz; Andrew Schmidt; Samuel Clark; Ali Khademhosseini; Amir Sheikhi
Journal:  Mater Today Chem       Date:  2021-12-30

3.  Diffusion of small molecule drugs is affected by surface interactions and crowder proteins.

Authors:  Debabrata Dey; Ariane Nunes-Alves; Rebecca C Wade; Gideon Schreiber
Journal:  iScience       Date:  2022-09-07

4.  Label-free isolation of a prostate cancer cell among blood cells and the single-cell measurement of drug accumulation using an integrated microfluidic chip.

Authors:  A Khamenehfar; T V Beischlag; P J Russell; M T P Ling; C Nelson; P C H Li
Journal:  Biomicrofluidics       Date:  2015-11-12       Impact factor: 2.800

5.  Evaluation of immune-modulating drugs for use in drug-eluting microsphere transarterial embolization.

Authors:  Andrew S Mikhail; Michal Mauda-Havakuk; Ayele H Negussie; Natalie Hong; Natalie M Hawken; Camella J Carlson; Joshua W Owen; Olga Franco-Mahecha; Paul G Wakim; Andrew L Lewis; William F Pritchard; John W Karanian; Bradford J Wood
Journal:  Int J Pharm       Date:  2022-01-20       Impact factor: 6.510

6.  The tumor-inhibitory effectiveness of a novel anti-Trop2 Fab conjugate in pancreatic cancer.

Authors:  Yuan Mao; Xiaoying Wang; Feng Zheng; Changjun Wang; Qi Tang; Xiaojun Tang; Ning Xu; Huiling Zhang; Dawei Zhang; Lin Xiong; Jie Liang; Jin Zhu
Journal:  Oncotarget       Date:  2016-04-26

7.  Apoferritin as an ubiquitous nanocarrier with excellent shelf life.

Authors:  Simona Dostalova; Katerina Vasickova; David Hynek; Sona Krizkova; Lukas Richtera; Marketa Vaculovicova; Tomas Eckschlager; Marie Stiborova; Zbynek Heger; Vojtech Adam
Journal:  Int J Nanomedicine       Date:  2017-03-24

8.  Building Nanostructures with Drugs.

Authors:  Wang Ma; Andrew G Cheetham; Honggang Cui
Journal:  Nano Today       Date:  2016-02       Impact factor: 20.722

9.  Dual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo.

Authors:  Ke Zheng; Rui Li; Xiaolei Zhou; Ping Hu; Yaxin Zhang; Yunmei Huang; Zhuo Chen; Mingdong Huang
Journal:  Int J Nanomedicine       Date:  2015-08-24

10.  Doxorubicin-loaded cell-derived nanovesicles: an alternative targeted approach for anti-tumor therapy.

Authors:  Wei Jiang Goh; Choon Keong Lee; Shui Zou; Esther Cy Woon; Bertrand Czarny; Giorgia Pastorin
Journal:  Int J Nanomedicine       Date:  2017-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.